Bridgeway Capital Management, LLC Tela Bio, Inc. Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Tela Bio, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 103,000 shares of TELA stock, worth $300,760. This represents 0.01% of its overall portfolio holdings.

Number of Shares

103,000

Previous 53,000 94.34%

Holding current value

$300,760

Previous $249,000 4.42%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.32 - $5.04 $115,999 - $252,000	50,000 Added 94.34%	103,000 $260,000
Q2 2024 Aug 14, 2024	BUY	$4.39 - $6.36 $70,240 - $101,760	16,000 Added 43.24%	53,000 $249,000
Q1 2024 May 15, 2024	SELL	$5.3 - $7.61 $222,600 - $319,620	-42,000 Reduced 53.16%	37,000 $209,000
Q4 2023 Feb 14, 2024	BUY	$4.5 - $7.51 $90,000 - $150,200	20,000 Added 33.9%	79,000 $522,000
Q3 2022 Nov 14, 2022	SELL	$7.36 - $9.15 $132,480 - $164,700	-18,000 Reduced 23.38%	59,000 $503,000
Q2 2022 Aug 15, 2022	BUY	$5.54 - $11.49 $83,100 - $172,350	15,000 Added 24.19%	77,000 $547,000
Q3 2021 Nov 15, 2021	SELL	$12.2 - $15.93 $305,000 - $398,250	-25,000 Reduced 28.74%	62,000 $847,000
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $483,209 - $665,343	41,300 Added 90.37%	87,000 $1.4 Million
Q1 2021 May 17, 2021	BUY	$12.84 - $17.26 $586,788 - $788,782	45,700 New	45,700 $681,000
Q3 2020 Nov 16, 2020	SELL	$11.64 - $16.86 $217,668 - $315,282	-18,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.75 - $22.61 $67,425 - $196,707	8,700 Added 87.0%	18,700 $242,000
Q1 2020 May 15, 2020	BUY	$5.39 - $18.33 $53,900 - $183,299	10,000 New	10,000 $78,000

Others Institutions Holding TELA

# of Institutions

Shares Held

18.3M

Call Options Held

759K

Put Options Held

100

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $55.9M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Tela Bio, Inc. Transaction History